Top Sell
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 2 | 4 | 0 | 0 | 3,06 € | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | 1,90 € | 3,00 € | 57,81 % |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | 0,66 € | - | - |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 0 | 11,04 € | 26,71 € | 141,98 % |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | 0,92 € | 6,49 € | 606,48 % |
| Ionis Pharmaceuticals Inc. | 19 | 5 | 2 | 0 | 34,40 € | 56,86 € | 65,30 % |
| Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | 1,55 € | 18,37 € | 1084,90 % |
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | 0,89 € | - | - |
| T2 Biosystems Inc. | 0 | 11 | 0 | 0 | 0,16 € | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | 0,35 € | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | 0,98 € | - | - |
| Acadia Pharmaceuticals | 28 | 1 | 6 | 0 | 13,74 € | 31,78 € | 131,33 % |
| Avinger Inc. | 2 | 7 | 0 | 0 | 0,34 € | 4,64 € | 1272,63 % |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | 39,26 € | 67,64 € | 72,29 % |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | 0,33 € | 1,60 € | 381,93 % |
| Arca Biopharma | 0 | 21 | 0 | 1 | 3,00 € | - | - |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 1 | 3,27 € | 5,00 € | 53,14 % |
| Savara Inc. | 1 | 1 | 0 | 1 | 4,62 € | 8,00 € | 73,16 % |
| Trevena Inc. | 2 | 14 | 1 | 1 | 0,34 € | 6,48 € | 1784,30 % |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | 3,40 € | 8,27 € | 143,48 % |
| Cytomx Therapeutics Inc | 1 | 1 | 1 | 1 | 1,72 € | 50,00 € | 2810,36 % |
| Minerva Neurosciences Inc. | 0 | 5 | 0 | 1 | 2,30 € | - | - |
| Organovo Holdings Inc. | 0 | 7 | 0 | 2 | 0,96 € | 3,00 € | 213,15 % |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 2 | 2,78 € | - | - |
| Evoke Pharma Inc. | 0 | 24 | 0 | 2 | 0,41 € | - | - |